Manejo del cáncer cérvico uterino localmente avanzado

0Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Cervical cancer is one of the most common invasive neoplasia in women in underdeveloped countries. In an effort to improve treatment outcomes neoadjuvant chemotherapy, adjuvant and concurrent chemoradiation has been tested. Five randomized trials and two meta-analysis studying cisplatin-based chemoradiation have demonstrated a significant survival advantage. Based on the results of these five randomized trials the National Cancer Institute released a clinical announcement stating that cisplatin-based chemoradiotherapy as the new standard therapy for locally advanced cervical cancer. Although these treatment advances have improved the cure rate for women with locally advanced cervical cancer, a large percentage of women will die of locally recurrent and metastatic cancer. This review will critically evaluate the evidence supporting the available treatment modalities for locally advanced cancer of the uterine cervix.

Cite

CITATION STYLE

APA

Solís C., J. (2006). Manejo del cáncer cérvico uterino localmente avanzado. Revista Chilena de Obstetricia y Ginecologia. https://doi.org/10.4067/s0717-75262006000500010

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free